2022 SPEAKERS
Danjuma Adda, AMR Patient Alliance
Nicholas Adomakoh, Medical Director, Sandoz
Mark Albrecht, Branch Chief - Antibacterials Program, BARDA
Najy Alsayed, Head of Disease Area, Infectious Diseases, Menarini Group
Anand Anandkumar, Chief Executive Officer, Bugworks Research
James Anderson , Executive Director Global Health , IFPMA
Cristina Baker, Director of Medical Affairs, Cepheid
Daniel Bausch, Senior Director, Emerging Threats & Global Health Security President, FIND the global alliance for diagnostics
Jason Bay, Senior Director, Government Digital Services, Government Technology Agency of Singapore
Xavier Becerra, Secretary, U.S. Department of Health & Human Services
Mohammed Benghezal, Global Project Lead, Debiopharm
Peter Beyer, Senior Advisor, World Health Organisation
Christopher Bland, Clinical and Administrative Pharmacy, University of Georgia
Gerald Bloom, Professorial Fellow, Institute of Development Studies
Ken Blount, chief scientific officer, Rebiotix, a Ferring Company
April Bobenchik, Medical Director Microbiology, Associate Professor Pathology, Penn State Hershey Medical Center
Robert Bollinger, Raj and Kamla Gupta Professor of Infectious Disease, The Johns Hopkins University School of Medicine
Maria Elena Bottazzi, Co-Director, Texas Children’s Hospital Center for Vaccine Development, Baylor College of Medicine
Steve Brooks, Advisor, AMR Industry Alliance
Angella Browne, Infection Control Officer, Howard University Hospital
Ed Buurman, Director Alliances, CARB-X
Charles Cairns, Professor of Medicine and Emergency Medicine Senior Vice President, Medical Affairs, Drexel University
Kim Chapin-Robertson, Chief Medical Officer, Cepheid
Ricardo Chaves, Executive Medical Director Infectious Diseases, Debiopharm
Leonid Chindelevitch, Lecturer in Infectious Disease Epidemiology, Imperial College London
Robin Cohen, Chief Commercial Officer, Emergex Vaccines
Alexandre Costa, Diagnostics Adviser / AMR focal point, UNICEF
Michael Craig, Senior Advisor For Antibiotic Resistance, Antibiotic Resistance Coordination And Strategy Unit, Centers for Disease Control and Prevention
Natalie D'Amore, Head of External Innovation, Seres Therapeutics Inc
Aleksandar Danilovski, Chief Scientific Officer, Xellia Pharmaceuticals
Matt Davis, Tele-stewardship pharmacist, Infectious Disease Connect
César De La Fuente, Presidential Assistant Professor At Upenn And Leader, Machine Biology Group, University of Pennsylvania
Robert Deluccia, Executive Chairman, Acurx Pharmaceuticals
Sarah Despres, Counselor for Public Health and Science, U.S. Department of Health & Human Services
Michele Dilizia, Vice President Regulatory Affairs and Microbiology, Co-inventor of RECCE antibiotics, Recce Pharmaceuticals
Elizabeth Dodds Ashley, Associate Professor of Medicine with the Division of Infectious Diseases and International Health, Duke University
Simon Doherty, Senior LEcturer, Queen’s University Belfast
Michael Dudley, President, Chief Executive Officer and Co-founder, Qpex Biopharma
Erin Duffy, R&D Chief, CARB-X
Aleks Engel, Director, REPAIR Impact Fund, Novo Holdings
Yann Ferrisse, Head of Business Development, GARDP Foundation
David Findlay, Co Founder and Chief Executive Officer, Rosa Therapeutics Ltd
Diane Flayhart, Global Program Leader, Amr, Becton Dickinson
Vance Fowler, Professor In Molecular Genetics And Microbiology,, Duke Clinical Research Institute, Duke University Medical Center
Dan Freedberg, Assistant Professor, Columbia University
Paul Garofolo, Chief Executive Officer, Locus Biosciences, Inc.
Valeria Gigante, Team Lead, World Health Organization
Marc Gitzinger, Vice President, Beam Alliance
Jon Glaudemans, Executive Director of National Sepsis Data Trust Initiative, Sepsis Alliance
Debbie Goff, Infectious Diseases Specialist, College Of Pharmacy, Ohio State University Medical Center
Jaideep Gogtay, Chief Medical Officer, Cipla
Anna Govett, Programme Lead, Future Leaders Against AMR
Alwyn Hart, Lead Scientist, Environment Agency UK Government
Martin Heidecker, Chief Investment Officer, AMR Action Fund
Moska Hellamand, Lead researcher in AMR, Access to Medicine Foundation
Matthew Henn, EVP, Chief Scientific Officer, Seres Therapeutics Inc
Thomas Heymann, Executive Director, Sepsis Alliance
Amanda Horstman-Smith, Science and Technology Manager, Defense Threat Reduction Agency
Susan Huang, Professor, University of California, Irvine
Peter Jackson, Executive Officer, Infex Therapeutics
John Jernigan, Chief, Epidemiology Research, and Innovations Branch, Centers for Disease Control and Prevention
Amanda Jezek, Senior Vice President, Public Policy And Government Relations, Infectious Diseases Society of America
Kris Johansen, Associate Director of External Relations, NIAMRRE
Charley John, Director, Us Public Policy, Walgreen Co.
Melissa Johnson, Associate Professor of Medicine and Liaison Clinical Pharmacist, Duke University Medical Center
Mark Jones, Head of Preclinical Development, Basilea Pharmaceutica Ltd
Carriayne Jonesparr, Head of US Southeast Region, UK Science and Innovation Network
Mohan Joshi, Senior Principal Technical Advisor, USAID MTaPS
Anil Kaul, Clinical Professor, Director COVID-19 Diagnostic Laboratory, Oklahoma State University
Mark Kazmierczak, SME, PACCARB
Steve Kearney, Global Medical Director, SAS
Denise Kelly, Advisor - Microbiome Expert, Seventure
Bill Keough, Director, Institute for Supply Chain Development
Wes Kim, Assistant Director of Global Public Health Programs, American Society for Microbiology
Peter Kim, Clinical Team Leader, CBER, Food and Drug Administration (FDA)
Riko Kimoto, Senior Project Manager, Asia-Europe Foundation
Jason Kindrachuk, Assistant Professor, Canada Research Chair in Emerging Viruses, University of Manitoba
Amy Kirby, Microbiologist, Waterborne Disease Prevention Branch Dfwed-Ncezid, CDC
Jeremy Knox, Head of Policy, Infectious Disease, Wellcome Trust
Akhila Kosaraju, Chief Executive Officer and President, Phare Bio
Jennifer L. Rakeman, Senior Director, Medical Affairs, Public Health Programs, Cepheid
Karim Lalji, Chief Executive Officer, Microbion Pharma Corp.
Christian Lillis, Co-founder and Executive Director, Peggy Lillis Foundation
Benjamin Liu, Assistant Professor, Children’s National Hospital/George Washington Univ
Syra Madad, Senior Director, System-wide Special Pathogens Program, NYC Health + Hospitals
Shelley Magill, Division of Healthcare Quality Promotion, CDC
Peter Marks, Director, Center For Biologics Evaluation And Research (CBER), U.S. Food and Drug Administration
Clifford Martin, Assistant Clinical Professor of Medicine, University of Arizona
Sarah McCClelland, Public Health Analyst, Depatment of Health and Human Service
Daniel Mcquillen, President, Infectious Diseases Society of America IDSA
Greg Merril, Chief Executive Officer, Adaptive Phage Therapeutics
Marc Meyer, Director of Pharmacy Services, Infection Control, Southwest Health System
Sheila Miknyoczki, Project officer, BARDA
Mary Millard, Patient Advocate, Sepsis Survivor
Melissa Mitchell, Secretariat Lead, AMR Industry Alliance
Anne Moore, PI, University Colleague Cork
Gareth Morgan, Senior Vice President, Head, Global Portfolio Management, Shionogi inc
Bill Mudge, Director/ Co-Producer, Recombinant Films
Jean Mudge, Scriptwriter/ Co-Producer, Recombinant Films
Jomana Musmar, Senior Public Health Advisor, PACCARB
Mandy Nevel, Head of Animal Health and Welfare, Agriculture and Horticulture Development Board (ADHB)
Riccardo NIsato, Licensing and Grants Associate Manager, Debiopharm
Yasmina Noubia Abdiche, CSO and Co-founder, Revelar Biotherapeutics
Lesley Ogilvie, Interim Secretariat Lead, Global AMR R&D Hub
Deborah O'Neil, Chief Executive & Scientific Officer, NovaBiotics Ltd
Kevin Outterson, Professor, Boston University, Executive Director, CARB-X
Jean-Pierre Paccaud, Director BD, Jean-Pierre Paccaud
Phil Packer, Innovation Lead AMR and Vaccines, Innovate UK
Javad Parvizi, Professor of Orthopaedic Surgery, Sidney Kimmel School of Medicine
Carol Pearson, Health Reporter, Voice of America
Gabriel Pedone, AMR Business Manager, Biomerieux INC
Jessica Petrillo, Senior Advisor for AMR and GHSA, U.S. Agency for International Developemnt
Paul Plummer, Executive Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE)
Kavi Ramjeet, Head of Business Intelligence, FIND the global alliance for diagnostics
Brian Raux, Medical Science Liaison, Biomerieux
David Ripin, EVP, Infectious Diseases & Chief Science Officer, Clinton Health Access Initiative, Inc.
Tim Rodwell, Professor, University of California San Diego
Jerald Sadoff, Senior Advisor Vaccine Development, Janssen Vaccines & Prevention B.V.
Hatim Sati, Technical Officer, WHO AMR Global Coordination, World Health Organization
Aaron Sato, Chief Scientific Officer of Twist Biopharma, Twist Bioscience
Monika Schneider, Director, Global AMR Policy, Shionogi, Inc
Rick Sciotti, Chief, Drug Development Section, NIAID
Diane Shader Smith, AMR Advocate and Author, -
Fei Shen, Investment Director, Boehringer Ingelheim Venture Fund
Henry Skinner, Chief Executive Officer, AMR Action Fund
James Snyder, Professor Department of Pathology and Laboratory Medicine and Chief of Microbiology, University of Louisville
Boumediene Soufi, Global Head AMR, Sandoz
Sarah Spitznogle, Transplant Infectious Diseases Clinical Pharmacist, UT Southwestern Medical Center
Anita Suresh, Deputy Director of Genomics & Sequencing, FIND the global alliance for diagnostics
Fred Tenover, Vice President Of Scientific Affairs, Cepheid
Alba Tiley, Head Global Sustainable Antibiotics Program, Centrient Pharmaceuticals
Andrew Tomaras, Chief Scientific Officer, Forge Therapeutics
Maarten van der Heijden, Technical Officer, WHO
Monique Van Hoek, Professor School Of Systems Biology, George Mason University, College of Science
Marijn Verhoef, Director of Research and Operations, Access to Medicine Foundation
Rolf Wagenaar, Principal, CD&E Consulting LLC
Emily Wheeler, Director, Infectious Disease Policy, Biotechnology Innovation Organization (BIO)
Joanna Wieccek, Chief Scientific Officer, CircaGene
Hsiu Wu, Lead, NHSN AMR Team, CDC
Kalvin Yu, Medical Director, Medical Informatics, BD Insights Life Sciences
Milan Zdravkovic, CMO, Head of R&D, SNIPR BIOME
Angela Zhou, Scientific Content Creation and Development Supervisor, American Chemical Society
Ghada Zoubiane, head of partnerships and stakeholder engagement, International Centre for AMR solutions
Get involved at Disease Prevention & Control Summit America
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events